Journal article
Characterizing Frailty in Myeloproliferative Neoplasms: Baseline Results from the Orchid Study
Abstract
Background: Contemporary treatment of Myeloproliferative Neoplasms (MPNs) has altered their natural history. Frailty, a state of reduced physiologic reserve is prevalent among older individuals, and increases risk for cardiovascular disease (CVD) and other adverse health outcomes. However, little is known about frailty in MPNs. An improved characterization of frailty may inform MPN treatment goals including the impact of treatment on frailty …
Authors
Chornenki NLJ; Karampatos S; Leong D; Siegal DM; Hillis CM
Journal
Blood, Vol. 136, No. Supplement 1, pp. 9–10
Publisher
American Society of Hematology
Publication Date
November 5, 2020
DOI
10.1182/blood-2020-134557
ISSN
0006-4971